Recently, our company has reached a strategic cooperation with Boya united pharmaceutical institute CO.,LTD. on the Toutongding Syrup (100ml/bottle), to obtain the exclusive agency of the product.
MoreThe 2018 Guangdong Medical Association Academic Conference on Gastroenterology, sponsored by the Guangdong Medical Association
MoreOctober 4, 2018 Shionogi & Co., Ltd, Osaka, Japan, announced the latest results of the global Phase III study evaluating the anti-influenza drug baloxavir in high-risk individuals with influenza-related complications (CAPSTONE-2) at IDWeek, held
MoreAulimodi raw materials and tablets received clinical approval from the NMPA on October 18, 2016.
MoreFlumarin® (flomoxef sodium for injection), the original product of Shionogi in Japan, exclusively distributed by us, and is currently a medical insurance drug in Hunan and Heilongjiang provinces, specifically, in provincial medical insurance class B.
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mail[email protected]
Official WeChat account Mobile page